Of the five sarcomas that did not show diffuse myostatin expression, complete loss was seen in both pleomorphic rhabdomyosarcomas (PRMSs) (Figure S4), while the remaining three—each a high-grade myxofibrosarcoma (MFS)—showed focal or very focal expression (Figure S3). The gene discussed is MSTN; the disease is Marfan syndrome.